Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung Cancer.
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP.
Value-Based Medicine and Integration of Tumor Biology.
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies. J Clin Med. 2024 Jun 05; 13(11).
View in:
PubMed
authors with profiles
Ravi Salgia